Schizophrenia polygenic risk scores, clinical variables and genetic pathways as predictors of phenotypic traits of bipolar I disorder.

Bipolar disorder subphenotypes Individual pathway analysis Psychosis Schizophrenia polygenic score

Journal

Journal of affective disorders
ISSN: 1573-2517
Titre abrégé: J Affect Disord
Pays: Netherlands
ID NLM: 7906073

Informations de publication

Date de publication:
17 Apr 2024
Historique:
received: 17 12 2023
revised: 05 04 2024
accepted: 16 04 2024
medline: 20 4 2024
pubmed: 20 4 2024
entrez: 19 4 2024
Statut: aheadofprint

Résumé

We investigated the predictive value of polygenic risk scores (PRS) derived from the schizophrenia GWAS (Trubetskoy et al., 2022) (SCZ3) for phenotypic traits of bipolar disorder type-I (BP-I) in 1878 BP-I cases and 2751 controls from Romania and UK. We used PRSice-v2.3.3 and PRS-CS for computing SCZ3-PRS for testing the predictive power of SCZ3-PRS alone and in combination with clinical variables for several BP-I subphenotypes and for pathway analysis. Non-linear predictive models were also used. SCZ3-PRS significantly predicted psychosis, incongruent and congruent psychosis, general age-of-onset (AO) of BP-I, AO-depression, AO-Mania, rapid cycling in univariate regressions. A negative correlation between the number of depressive episodes and psychosis, mainly incongruent and an inverse relationship between increased SCZ3-SNP loading and BP-I-rapid cycling were observed. In random forest models comparing the predictive power of SCZ3-PRS alone and in combination with nine clinical variables, the best predictions were provided by combinations of SCZ3-PRS-CS and clinical variables closely followed by models containing only clinical variables. SCZ3-PRS performed worst. Twenty-two significant pathways underlying psychosis were identified. The combined RO-UK sample had a certain degree of heterogeneity of the BP-I severity: only the RO sample and partially the UK sample included hospitalized BP-I cases. The hospitalization is an indicator of illness severity. Not all UK subjects had complete subphenotype information. Our study shows that the SCZ3-PRS have a modest clinical value for predicting phenotypic traits of BP-I. For clinical use their best performance is in combination with clinical variables.

Identifiants

pubmed: 38640977
pii: S0165-0327(24)00678-5
doi: 10.1016/j.jad.2024.04.066
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest None of the authors have any conflict of interest to declare.

Auteurs

Maria Grigoroiu-Serbanescu (M)

Psychiatric Genetics Research Unit, Alexandru Obregia Clinical Psychiatric Hospital, Bucharest, Romania. Electronic address: maria.serbanescu@gmail.com.

Tracey van der Veen (T)

Molecular Psychiatry Laboratory, Division of Psychiatry, University College London, London, UK.

Tim Bigdeli (T)

SUNY Downstate Medical Center, Brooklyn, NY, USA.

Stefan Herms (S)

Department of Biomedicine, University of Basel, Basel, Switzerland; Institute of Human Genetics, University of Bonn, School of Medicine, University Hospital Bonn, Germany.

Carmen C Diaconu (CC)

Stefan S Nicolau Institute of Virology, Bucharest, Romania.

Ana Iulia Neagu (AI)

Stefan S Nicolau Institute of Virology, Bucharest, Romania.

Nicholas Bass (N)

Molecular Psychiatry Laboratory, Division of Psychiatry, University College London, London, UK.

Johan Thygesen (J)

Molecular Psychiatry Laboratory, Division of Psychiatry, University College London, London, UK; Institute of Health Informatics, University College London, London, UK.

Andreas J Forstner (AJ)

Institute of Human Genetics, University of Bonn, School of Medicine, University Hospital Bonn, Germany.

Markus M Nöthen (MM)

Institute of Human Genetics, University of Bonn, School of Medicine, University Hospital Bonn, Germany.

Andrew McQuillin (A)

Molecular Psychiatry Laboratory, Division of Psychiatry, University College London, London, UK.

Classifications MeSH